In the present study, we demonstrated that human skin cancers frequently overexpress TGF-β1 but exhibit decreased expression of the TGF-β type II receptor (TGF-βRII). To understand how this combination affects cancer prognosis, we generated a transgenic mouse model that allowed inducible expression of TGF-β1 in keratinocytes expressing a dominant negative TGF-βRII (ΔβRII) in the epidermis. Without ΔβRII expression, TGF-β1 transgene induction in late-stage, chemically induced papillomas failed to inhibit tumor growth but increased metastasis and epithelial-to-mesenchymal transition (EMT), i.e., formation of spindle cell carcinomas. Interestingly, ΔβRII expression abrogated TGF-β1–mediated EMT and was accompanied by restoration of membrane-associated E-cadherin/catenin complex in TGF-β1/ΔβRII compound tumors. Furthermore, expression of molecules thought to mediate TGF-β1–induced EMT was attenuated in TGF-β1/ΔβRII–transgenic tumors. However, TGF-β1/ΔβRII–transgenic tumors progressed to metastasis without losing expression of the membrane-associated E-cadherin/catenin complex and at a rate higher than those observed in nontransgenic, TGF-β1–transgenic, or ΔβRII-transgenic mice. Abrogation of Smad activation by ΔβRII correlated with the blockade of EMT. However, ΔβRII did not alter TGF-β1–mediated expression of RhoA/Rac and MAPK, which contributed to increased metastasis. Our study provides evidence that TGF-β1 induces EMT and invasion via distinct mechanisms. TGF-β1–mediated EMT requires functional TGF-βRII, whereas TGF-β1–mediated tumor invasion cooperates with reduced TGF-βRII signaling in tumor epithelia.
Gangwen Han, Shi-Long Lu, Allen G. Li, Wei He, Christopher L. Corless, Molly Kulesz-Martin, Xiao-Jing Wang
Title and authors | Publication | Year |
---|---|---|
Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer
P Maris, A Blomme, AP Palacios, B Costanza, A Bellahcène, E Bianchi, S Gofflot, P Drion, GE Trombino, ED Valentin, PG Cusumano, S Maweja, G Jerusalem, P Delvenne, E Lifrange, V Castronovo, A Turtoi, C Kemp |
PLoS Medicine | 2015 |
Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial–mesenchymal transition in non-small-cell lung cancer
L Wang, H Yang, Z Lei, J Zhao, Y Chen, P Chen, C Li, Y Zeng, Z Liu, X Liu, HT Zhang |
Oncogene | 2015 |
Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for Therapy
A Hay, I Ganly |
Rare Cancers and Therapy | 2015 |
Extracellular acidity strengthens mesenchymal stem cells to promote melanoma progression
S Peppicelli, F Bianchini, A Toti, A Laurenzana, G Fibbi, L Calorini |
Cell cycle (Georgetown, Tex.) | 2015 |
Molecular Aspects of Head and Neck Cancer Therapy
SV Puram, JW Rocco |
Hematology/Oncology Clinics of North America | 2015 |
Epithelial-mesenchymal transition during extravillous trophoblast differentiation
JE Davies, J Pollheimer, HE Yong, MI Kokkinos, B Kalionis, M Knöfler, P Murthi |
Cell adhesion & migration | 2015 |
KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2
Q Yan, W Zhang, Y Wu, M Wu, M Zhang, X Shi, J Zhao, Q Nan, Y Cheng, L Wang, T Cheng, J Li, Y Bai, S Liu, J Wang |
Oncotarget | 2015 |
Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling
HL Jiang, HF Sun, SP Gao, LD Li, X Hu, J Wu, W Jin |
Oncotarget | 2015 |